The global Epilepsy Treatment Drug market was valued at US$ 19010 million in 2023 and is anticipated to reach US$ 26510 million by 2030, witnessing a CAGR of 4.9% during the forecast period 2024-2030.

Epilepsy Treatment Drug Market

Epilepsy medications are medications used to manage and relieve epileptic seizures. These drugs can be divided into traditional anti-epileptic drugs (AEDs) and new generation anti-epileptic drugs. The field of drug development is constantly emerging with new anti-epileptic drugs that are generally safer, more effective, and have fewer adverse effects. The development of new drugs also includes drugs for different types of epilepsy. Overall, the field of epilepsy treatment is experiencing many innovations and advances with the goal of providing safer and more effective treatments to improve patients' quality of life. With the continuous development of scientific research and medical technology, future epilepsy treatment will be more individualized and precise.

This report aims to provide a comprehensive presentation of the global market for Epilepsy Treatment Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Epilepsy Treatment Drug.

Report Scope

The Epilepsy Treatment Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Epilepsy Treatment Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Epilepsy Treatment Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Epilepsy Treatment Drug Market Report

Report Metric	Details
Report Name	Epilepsy Treatment Drug Market
Accounted market size in 2023	US$ 19010 million
Forecasted market size in 2030	US$ 26510 million
CAGR	4.9%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Traditional Anti-Epileptic Drug A New Generation of Anti-Epileptic Drug Others
Segment by Application	Pharmacy Hospital Clinic
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Pfizer, UCB, Novartis AG, GlaxoSmithKline, Sanofi, Eisai, Johnson & Johnson, Takeda Pharmaceutical Company, Sumitomo Pharma, Abbott Laboratories, TEVA Pharmaceutical Industries, Viatris, Merck, SK Biopharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Epilepsy Treatment Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Epilepsy Treatment Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Epilepsy Treatment Drug Market growing?

Ans: The Epilepsy Treatment Drug Market witnessing a CAGR of 4.9% during the forecast period 2024-2030.

What is the Epilepsy Treatment Drug Market size in 2030?

Ans: The Epilepsy Treatment Drug Market size in 2030 will be US$ 26510 million.

Who are the main players in the Epilepsy Treatment Drug Market report?

Ans: The main players in the Epilepsy Treatment Drug Market are Pfizer, UCB, Novartis AG, GlaxoSmithKline, Sanofi, Eisai, Johnson & Johnson, Takeda Pharmaceutical Company, Sumitomo Pharma, Abbott Laboratories, TEVA Pharmaceutical Industries, Viatris, Merck, SK Biopharmaceuticals

What are the Application segmentation covered in the Epilepsy Treatment Drug Market report?

Ans: The Applications covered in the Epilepsy Treatment Drug Market report are Pharmacy, Hospital, Clinic

What are the Type segmentation covered in the Epilepsy Treatment Drug Market report?

Ans: The Types covered in the Epilepsy Treatment Drug Market report are Traditional Anti-Epileptic Drug, A New Generation of Anti-Epileptic Drug, Others

1 Epilepsy Treatment Drug Market Overview

1.1 Product Overview and Scope of Epilepsy Treatment Drug

1.2 Epilepsy Treatment Drug Segment by Type

1.2.1 Global Epilepsy Treatment Drug Market Value Comparison by Type (2024-2030)

1.2.2 Traditional Anti-Epileptic Drug

1.2.3 A New Generation of Anti-Epileptic Drug

1.2.4 Others

1.3 Epilepsy Treatment Drug Segment by Application

1.3.1 Global Epilepsy Treatment Drug Market Value by Application: (2024-2030)

1.3.2 Pharmacy

1.3.3 Hospital

1.3.4 Clinic

1.4 Global Epilepsy Treatment Drug Market Size Estimates and Forecasts

1.4.1 Global Epilepsy Treatment Drug Revenue 2019-2030

1.4.2 Global Epilepsy Treatment Drug Sales 2019-2030

1.4.3 Global Epilepsy Treatment Drug Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Epilepsy Treatment Drug Market Competition by Manufacturers

2.1 Global Epilepsy Treatment Drug Sales Market Share by Manufacturers (2019-2024)

2.2 Global Epilepsy Treatment Drug Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Epilepsy Treatment Drug Average Price by Manufacturers (2019-2024)

2.4 Global Epilepsy Treatment Drug Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Epilepsy Treatment Drug, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Epilepsy Treatment Drug, Product Type & Application

2.7 Epilepsy Treatment Drug Market Competitive Situation and Trends

2.7.1 Epilepsy Treatment Drug Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Epilepsy Treatment Drug Players Market Share by Revenue

2.7.3 Global Epilepsy Treatment Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Epilepsy Treatment Drug Retrospective Market Scenario by Region

3.1 Global Epilepsy Treatment Drug Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Epilepsy Treatment Drug Global Epilepsy Treatment Drug Sales by Region: 2019-2030

3.2.1 Global Epilepsy Treatment Drug Sales by Region: 2019-2024

3.2.2 Global Epilepsy Treatment Drug Sales by Region: 2025-2030

3.3 Global Epilepsy Treatment Drug Global Epilepsy Treatment Drug Revenue by Region: 2019-2030

3.3.1 Global Epilepsy Treatment Drug Revenue by Region: 2019-2024

3.3.2 Global Epilepsy Treatment Drug Revenue by Region: 2025-2030

3.4 North America Epilepsy Treatment Drug Market Facts & Figures by Country

3.4.1 North America Epilepsy Treatment Drug Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Epilepsy Treatment Drug Sales by Country (2019-2030)

3.4.3 North America Epilepsy Treatment Drug Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Epilepsy Treatment Drug Market Facts & Figures by Country

3.5.1 Europe Epilepsy Treatment Drug Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Epilepsy Treatment Drug Sales by Country (2019-2030)

3.5.3 Europe Epilepsy Treatment Drug Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Epilepsy Treatment Drug Market Facts & Figures by Country

3.6.1 Asia Pacific Epilepsy Treatment Drug Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Epilepsy Treatment Drug Sales by Country (2019-2030)

3.6.3 Asia Pacific Epilepsy Treatment Drug Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Epilepsy Treatment Drug Market Facts & Figures by Country

3.7.1 Latin America Epilepsy Treatment Drug Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Epilepsy Treatment Drug Sales by Country (2019-2030)

3.7.3 Latin America Epilepsy Treatment Drug Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Epilepsy Treatment Drug Market Facts & Figures by Country

3.8.1 Middle East and Africa Epilepsy Treatment Drug Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Epilepsy Treatment Drug Sales by Country (2019-2030)

3.8.3 Middle East and Africa Epilepsy Treatment Drug Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Epilepsy Treatment Drug Sales by Type (2019-2030)

4.1.1 Global Epilepsy Treatment Drug Sales by Type (2019-2024)

4.1.2 Global Epilepsy Treatment Drug Sales by Type (2025-2030)

4.1.3 Global Epilepsy Treatment Drug Sales Market Share by Type (2019-2030)

4.2 Global Epilepsy Treatment Drug Revenue by Type (2019-2030)

4.2.1 Global Epilepsy Treatment Drug Revenue by Type (2019-2024)

4.2.2 Global Epilepsy Treatment Drug Revenue by Type (2025-2030)

4.2.3 Global Epilepsy Treatment Drug Revenue Market Share by Type (2019-2030)

4.3 Global Epilepsy Treatment Drug Price by Type (2019-2030)

5 Segment by Application

5.1 Global Epilepsy Treatment Drug Sales by Application (2019-2030)

5.1.1 Global Epilepsy Treatment Drug Sales by Application (2019-2024)

5.1.2 Global Epilepsy Treatment Drug Sales by Application (2025-2030)

5.1.3 Global Epilepsy Treatment Drug Sales Market Share by Application (2019-2030)

5.2 Global Epilepsy Treatment Drug Revenue by Application (2019-2030)

5.2.1 Global Epilepsy Treatment Drug Revenue by Application (2019-2024)

5.2.2 Global Epilepsy Treatment Drug Revenue by Application (2025-2030)

5.2.3 Global Epilepsy Treatment Drug Revenue Market Share by Application (2019-2030)

5.3 Global Epilepsy Treatment Drug Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Pfizer

6.1.1 Pfizer Corporation Information

6.1.2 Pfizer Description and Business Overview

6.1.3 Pfizer Epilepsy Treatment Drug Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Pfizer Epilepsy Treatment Drug Product Portfolio

6.1.5 Pfizer Recent Developments/Updates

6.2 UCB

6.2.1 UCB Corporation Information

6.2.2 UCB Description and Business Overview

6.2.3 UCB Epilepsy Treatment Drug Sales, Revenue and Gross Margin (2019-2024)

6.2.4 UCB Epilepsy Treatment Drug Product Portfolio

6.2.5 UCB Recent Developments/Updates

6.3 Novartis AG

6.3.1 Novartis AG Corporation Information

6.3.2 Novartis AG Description and Business Overview

6.3.3 Novartis AG Epilepsy Treatment Drug Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Novartis AG Epilepsy Treatment Drug Product Portfolio

6.3.5 Novartis AG Recent Developments/Updates

6.4 GlaxoSmithKline

6.4.1 GlaxoSmithKline Corporation Information

6.4.2 GlaxoSmithKline Description and Business Overview

6.4.3 GlaxoSmithKline Epilepsy Treatment Drug Sales, Revenue and Gross Margin (2019-2024)

6.4.4 GlaxoSmithKline Epilepsy Treatment Drug Product Portfolio

6.4.5 GlaxoSmithKline Recent Developments/Updates

6.5 Sanofi

6.5.1 Sanofi Corporation Information

6.5.2 Sanofi Description and Business Overview

6.5.3 Sanofi Epilepsy Treatment Drug Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Sanofi Epilepsy Treatment Drug Product Portfolio

6.5.5 Sanofi Recent Developments/Updates

6.6 Eisai

6.6.1 Eisai Corporation Information

6.6.2 Eisai Description and Business Overview

6.6.3 Eisai Epilepsy Treatment Drug Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Eisai Epilepsy Treatment Drug Product Portfolio

6.6.5 Eisai Recent Developments/Updates

6.7 Johnson & Johnson

6.6.1 Johnson & Johnson Corporation Information

6.6.2 Johnson & Johnson Description and Business Overview

6.6.3 Johnson & Johnson Epilepsy Treatment Drug Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Johnson & Johnson Epilepsy Treatment Drug Product Portfolio

6.7.5 Johnson & Johnson Recent Developments/Updates

6.8 Takeda Pharmaceutical Company

6.8.1 Takeda Pharmaceutical Company Corporation Information

6.8.2 Takeda Pharmaceutical Company Description and Business Overview

6.8.3 Takeda Pharmaceutical Company Epilepsy Treatment Drug Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Takeda Pharmaceutical Company Epilepsy Treatment Drug Product Portfolio

6.8.5 Takeda Pharmaceutical Company Recent Developments/Updates

6.9 Sumitomo Pharma

6.9.1 Sumitomo Pharma Corporation Information

6.9.2 Sumitomo Pharma Description and Business Overview

6.9.3 Sumitomo Pharma Epilepsy Treatment Drug Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Sumitomo Pharma Epilepsy Treatment Drug Product Portfolio

6.9.5 Sumitomo Pharma Recent Developments/Updates

6.10 Abbott Laboratories

6.10.1 Abbott Laboratories Corporation Information

6.10.2 Abbott Laboratories Description and Business Overview

6.10.3 Abbott Laboratories Epilepsy Treatment Drug Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Abbott Laboratories Epilepsy Treatment Drug Product Portfolio

6.10.5 Abbott Laboratories Recent Developments/Updates

6.11 TEVA Pharmaceutical Industries

6.11.1 TEVA Pharmaceutical Industries Corporation Information

6.11.2 TEVA Pharmaceutical Industries Epilepsy Treatment Drug Description and Business Overview

6.11.3 TEVA Pharmaceutical Industries Epilepsy Treatment Drug Sales, Revenue and Gross Margin (2019-2024)

6.11.4 TEVA Pharmaceutical Industries Epilepsy Treatment Drug Product Portfolio

6.11.5 TEVA Pharmaceutical Industries Recent Developments/Updates

6.12 Viatris

6.12.1 Viatris Corporation Information

6.12.2 Viatris Epilepsy Treatment Drug Description and Business Overview

6.12.3 Viatris Epilepsy Treatment Drug Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Viatris Epilepsy Treatment Drug Product Portfolio

6.12.5 Viatris Recent Developments/Updates

6.13 Merck

6.13.1 Merck Corporation Information

6.13.2 Merck Epilepsy Treatment Drug Description and Business Overview

6.13.3 Merck Epilepsy Treatment Drug Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Merck Epilepsy Treatment Drug Product Portfolio

6.13.5 Merck Recent Developments/Updates

6.14 SK Biopharmaceuticals

6.14.1 SK Biopharmaceuticals Corporation Information

6.14.2 SK Biopharmaceuticals Epilepsy Treatment Drug Description and Business Overview

6.14.3 SK Biopharmaceuticals Epilepsy Treatment Drug Sales, Revenue and Gross Margin (2019-2024)

6.14.4 SK Biopharmaceuticals Epilepsy Treatment Drug Product Portfolio

6.14.5 SK Biopharmaceuticals Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Epilepsy Treatment Drug Industry Chain Analysis

7.2 Epilepsy Treatment Drug Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Epilepsy Treatment Drug Production Mode & Process

7.4 Epilepsy Treatment Drug Sales and Marketing

7.4.1 Epilepsy Treatment Drug Sales Channels

7.4.2 Epilepsy Treatment Drug Distributors

7.5 Epilepsy Treatment Drug Customers

8 Epilepsy Treatment Drug Market Dynamics

8.1 Epilepsy Treatment Drug Industry Trends

8.2 Epilepsy Treatment Drug Market Drivers

8.3 Epilepsy Treatment Drug Market Challenges

8.4 Epilepsy Treatment Drug Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Takeda Pharmaceutical Company

Sumitomo Pharma

Abbott Laboratories

Teva Pharmaceutical Industries

Viatris

Merck

SK Biopharmaceuticals

List of Tables

Table 1. Global Epilepsy Treatment Drug Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Epilepsy Treatment Drug Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Epilepsy Treatment Drug Market Competitive Situation by Manufacturers in 2023

Table 4. Global Epilepsy Treatment Drug Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Epilepsy Treatment Drug Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Epilepsy Treatment Drug Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Epilepsy Treatment Drug Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Epilepsy Treatment Drug Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Epilepsy Treatment Drug, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Epilepsy Treatment Drug, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Epilepsy Treatment Drug, Product Type & Application

Table 12. Global Key Manufacturers of Epilepsy Treatment Drug, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Epilepsy Treatment Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Epilepsy Treatment Drug as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Epilepsy Treatment Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Epilepsy Treatment Drug Sales by Region (2019-2024) & (K Units)

Table 18. Global Epilepsy Treatment Drug Sales Market Share by Region (2019-2024)

Table 19. Global Epilepsy Treatment Drug Sales by Region (2025-2030) & (K Units)

Table 20. Global Epilepsy Treatment Drug Sales Market Share by Region (2025-2030)

Table 21. Global Epilepsy Treatment Drug Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Epilepsy Treatment Drug Revenue Market Share by Region (2019-2024)

Table 23. Global Epilepsy Treatment Drug Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Epilepsy Treatment Drug Revenue Market Share by Region (2025-2030)

Table 25. North America Epilepsy Treatment Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Epilepsy Treatment Drug Sales by Country (2019-2024) & (K Units)

Table 27. North America Epilepsy Treatment Drug Sales by Country (2025-2030) & (K Units)

Table 28. North America Epilepsy Treatment Drug Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Epilepsy Treatment Drug Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Epilepsy Treatment Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Epilepsy Treatment Drug Sales by Country (2019-2024) & (K Units)

Table 32. Europe Epilepsy Treatment Drug Sales by Country (2025-2030) & (K Units)

Table 33. Europe Epilepsy Treatment Drug Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Epilepsy Treatment Drug Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Epilepsy Treatment Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Epilepsy Treatment Drug Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Epilepsy Treatment Drug Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Epilepsy Treatment Drug Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Epilepsy Treatment Drug Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Epilepsy Treatment Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Epilepsy Treatment Drug Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Epilepsy Treatment Drug Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Epilepsy Treatment Drug Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Epilepsy Treatment Drug Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Epilepsy Treatment Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Epilepsy Treatment Drug Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Epilepsy Treatment Drug Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Epilepsy Treatment Drug Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Epilepsy Treatment Drug Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Epilepsy Treatment Drug Sales (K Units) by Type (2019-2024)

Table 51. Global Epilepsy Treatment Drug Sales (K Units) by Type (2025-2030)

Table 52. Global Epilepsy Treatment Drug Sales Market Share by Type (2019-2024)

Table 53. Global Epilepsy Treatment Drug Sales Market Share by Type (2025-2030)

Table 54. Global Epilepsy Treatment Drug Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Epilepsy Treatment Drug Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Epilepsy Treatment Drug Revenue Market Share by Type (2019-2024)

Table 57. Global Epilepsy Treatment Drug Revenue Market Share by Type (2025-2030)

Table 58. Global Epilepsy Treatment Drug Price (US$/Unit) by Type (2019-2024)

Table 59. Global Epilepsy Treatment Drug Price (US$/Unit) by Type (2025-2030)

Table 60. Global Epilepsy Treatment Drug Sales (K Units) by Application (2019-2024)

Table 61. Global Epilepsy Treatment Drug Sales (K Units) by Application (2025-2030)

Table 62. Global Epilepsy Treatment Drug Sales Market Share by Application (2019-2024)

Table 63. Global Epilepsy Treatment Drug Sales Market Share by Application (2025-2030)

Table 64. Global Epilepsy Treatment Drug Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Epilepsy Treatment Drug Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Epilepsy Treatment Drug Revenue Market Share by Application (2019-2024)

Table 67. Global Epilepsy Treatment Drug Revenue Market Share by Application (2025-2030)

Table 68. Global Epilepsy Treatment Drug Price (US$/Unit) by Application (2019-2024)

Table 69. Global Epilepsy Treatment Drug Price (US$/Unit) by Application (2025-2030)

Table 70. Pfizer Corporation Information

Table 71. Pfizer Description and Business Overview

Table 72. Pfizer Epilepsy Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Pfizer Epilepsy Treatment Drug Product

Table 74. Pfizer Recent Developments/Updates

Table 75. UCB Corporation Information

Table 76. UCB Description and Business Overview

Table 77. UCB Epilepsy Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. UCB Epilepsy Treatment Drug Product

Table 79. UCB Recent Developments/Updates

Table 80. Novartis AG Corporation Information

Table 81. Novartis AG Description and Business Overview

Table 82. Novartis AG Epilepsy Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Novartis AG Epilepsy Treatment Drug Product

Table 84. Novartis AG Recent Developments/Updates

Table 85. GlaxoSmithKline Corporation Information

Table 86. GlaxoSmithKline Description and Business Overview

Table 87. GlaxoSmithKline Epilepsy Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. GlaxoSmithKline Epilepsy Treatment Drug Product

Table 89. GlaxoSmithKline Recent Developments/Updates

Table 90. Sanofi Corporation Information

Table 91. Sanofi Description and Business Overview

Table 92. Sanofi Epilepsy Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Sanofi Epilepsy Treatment Drug Product

Table 94. Sanofi Recent Developments/Updates

Table 95. Eisai Corporation Information

Table 96. Eisai Description and Business Overview

Table 97. Eisai Epilepsy Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Eisai Epilepsy Treatment Drug Product

Table 99. Eisai Recent Developments/Updates

Table 100. Johnson & Johnson Corporation Information

Table 101. Johnson & Johnson Description and Business Overview

Table 102. Johnson & Johnson Epilepsy Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Johnson & Johnson Epilepsy Treatment Drug Product

Table 104. Johnson & Johnson Recent Developments/Updates

Table 105. Takeda Pharmaceutical Company Corporation Information

Table 106. Takeda Pharmaceutical Company Description and Business Overview

Table 107. Takeda Pharmaceutical Company Epilepsy Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Takeda Pharmaceutical Company Epilepsy Treatment Drug Product

Table 109. Takeda Pharmaceutical Company Recent Developments/Updates

Table 110. Sumitomo Pharma Corporation Information

Table 111. Sumitomo Pharma Description and Business Overview

Table 112. Sumitomo Pharma Epilepsy Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Sumitomo Pharma Epilepsy Treatment Drug Product

Table 114. Sumitomo Pharma Recent Developments/Updates

Table 115. Abbott Laboratories Corporation Information

Table 116. Abbott Laboratories Description and Business Overview

Table 117. Abbott Laboratories Epilepsy Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Abbott Laboratories Epilepsy Treatment Drug Product

Table 119. Abbott Laboratories Recent Developments/Updates

Table 120. TEVA Pharmaceutical Industries Corporation Information

Table 121. TEVA Pharmaceutical Industries Description and Business Overview

Table 122. TEVA Pharmaceutical Industries Epilepsy Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 123. TEVA Pharmaceutical Industries Epilepsy Treatment Drug Product

Table 124. TEVA Pharmaceutical Industries Recent Developments/Updates

Table 125. Viatris Corporation Information

Table 126. Viatris Description and Business Overview

Table 127. Viatris Epilepsy Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 128. Viatris Epilepsy Treatment Drug Product

Table 129. Viatris Recent Developments/Updates

Table 130. Merck Corporation Information

Table 131. Merck Description and Business Overview

Table 132. Merck Epilepsy Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 133. Merck Epilepsy Treatment Drug Product

Table 134. Merck Recent Developments/Updates

Table 135. SK Biopharmaceuticals Corporation Information

Table 136. SK Biopharmaceuticals Description and Business Overview

Table 137. SK Biopharmaceuticals Epilepsy Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 138. SK Biopharmaceuticals Epilepsy Treatment Drug Product

Table 139. SK Biopharmaceuticals Recent Developments/Updates

Table 140. Key Raw Materials Lists

Table 141. Raw Materials Key Suppliers Lists

Table 142. Epilepsy Treatment Drug Distributors List

Table 143. Epilepsy Treatment Drug Customers List

Table 144. Epilepsy Treatment Drug Market Trends

Table 145. Epilepsy Treatment Drug Market Drivers

Table 146. Epilepsy Treatment Drug Market Challenges

Table 147. Epilepsy Treatment Drug Market Restraints

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Epilepsy Treatment Drug

Figure 2. Global Epilepsy Treatment Drug Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Epilepsy Treatment Drug Market Share by Type in 2023 & 2030

Figure 4. Traditional Anti-Epileptic Drug Product Picture

Figure 5. A New Generation of Anti-Epileptic Drug Product Picture

Figure 6. Others Product Picture

Figure 7. Global Epilepsy Treatment Drug Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Epilepsy Treatment Drug Market Share by Application in 2023 & 2030

Figure 9. Pharmacy

Figure 10. Hospital

Figure 11. Clinic

Figure 12. Global Epilepsy Treatment Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Epilepsy Treatment Drug Market Size (2019-2030) & (US$ Million)

Figure 14. Global Epilepsy Treatment Drug Sales (2019-2030) & (K Units)

Figure 15. Global Epilepsy Treatment Drug Average Price (US$/Unit) & (2019-2030)

Figure 16. Epilepsy Treatment Drug Report Years Considered

Figure 17. Epilepsy Treatment Drug Sales Share by Manufacturers in 2023

Figure 18. Global Epilepsy Treatment Drug Revenue Share by Manufacturers in 2023

Figure 19. The Global 5 and 10 Largest Epilepsy Treatment Drug Players: Market Share by Revenue in 2023

Figure 20. Epilepsy Treatment Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 21. Global Epilepsy Treatment Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 22. North America Epilepsy Treatment Drug Sales Market Share by Country (2019-2030)

Figure 23. North America Epilepsy Treatment Drug Revenue Market Share by Country (2019-2030)

Figure 24. United States Epilepsy Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Canada Epilepsy Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Europe Epilepsy Treatment Drug Sales Market Share by Country (2019-2030)

Figure 27. Europe Epilepsy Treatment Drug Revenue Market Share by Country (2019-2030)

Figure 28. Germany Epilepsy Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. France Epilepsy Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. U.K. Epilepsy Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Italy Epilepsy Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Russia Epilepsy Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Epilepsy Treatment Drug Sales Market Share by Region (2019-2030)

Figure 34. Asia Pacific Epilepsy Treatment Drug Revenue Market Share by Region (2019-2030)

Figure 35. China Epilepsy Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Japan Epilepsy Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. South Korea Epilepsy Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. India Epilepsy Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Australia Epilepsy Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. China Taiwan Epilepsy Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Southeast Asia Epilepsy Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Latin America Epilepsy Treatment Drug Sales Market Share by Country (2019-2030)

Figure 43. Latin America Epilepsy Treatment Drug Revenue Market Share by Country (2019-2030)

Figure 44. Mexico Epilepsy Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Brazil Epilepsy Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Argentina Epilepsy Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Middle East & Africa Epilepsy Treatment Drug Sales Market Share by Country (2019-2030)

Figure 48. Middle East & Africa Epilepsy Treatment Drug Revenue Market Share by Country (2019-2030)

Figure 49. Turkey Epilepsy Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Saudi Arabia Epilepsy Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. UAE Epilepsy Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Global Sales Market Share of Epilepsy Treatment Drug by Type (2019-2030)

Figure 53. Global Revenue Market Share of Epilepsy Treatment Drug by Type (2019-2030)

Figure 54. Global Epilepsy Treatment Drug Price (US$/Unit) by Type (2019-2030)

Figure 55. Global Sales Market Share of Epilepsy Treatment Drug by Application (2019-2030)

Figure 56. Global Revenue Market Share of Epilepsy Treatment Drug by Application (2019-2030)

Figure 57. Global Epilepsy Treatment Drug Price (US$/Unit) by Application (2019-2030)

Figure 58. Epilepsy Treatment Drug Value Chain

Figure 59. Epilepsy Treatment Drug Production Process

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Distributors Profiles

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions